MedPath
HSA Approval

GLYCOMET-850 TABLET 850 mg

SIN11787P

GLYCOMET-850 TABLET 850 mg

GLYCOMET-850 TABLET 850 mg

January 26, 2002

ZYFAS PHARMA PTE LTD

ZYFAS MEDICAL CO

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS MEDICAL CO

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

A10BA02

metformin

Manufacturer Information

ZYFAS MEDICAL CO

USV Private Limited

USV PRIVATE LIMITED

Active Ingredients

METFORMIN HCl

850 mg

Metformin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

GLYCOMET-850 TABLET 850 mg - HSA Approval | MedPath